The Front-Runner to Replace Justice Kennedy: Brett Kavanaugh
*By Conor White*
The race to fill Justice Anthony Kennedy's seat on the Supreme Court is just beginning, but a front runner has already emerged, according to Heather Timmons, Quartz's White House correspondent.
"The name you're hearing the most in Washington has been Brett Kavanaugh," she explained. "He's a U.S. District Court of Appeals judge in DC, he clerked for Kennedy. Trump made a point of saying he's consulted with Kennedy about who his replacement should be, and it's expected that Kennedy is going to recommend Kavanaugh."
Despite reportedly being a late add to the president's list of potential nominees, 53-year-old Kavanaugh checks a lot of boxes for conservatives: he represented George W. Bush in the 2000 Florida recount, was a lawyer for Ken Starr during the investigation into Bill Clinton's affair with Monica Lewinsky, and most recently he dissented when his court upheld an opinion requiring the government to facilitate an abortion for an undocumented teen in U.S. custody.
In an interview Thursday on Cheddar, Timmons dove even deeper into why Kavanaugh could be Trump's pick.
"He has a history of pro-business rulings, he decided a case that said the Consumer Finance Protection Board was unconstitutional, which allowed Trump to replace the head of that with Mick Mulvaney."
And while many expect President Trump to attempt to ram through a nominee with a very conservative history in an effort to overturn Roe v. Wade, Timmons said that might not be the best move when it comes to the midterm elections.
"Right now support across America for legal abortion in most cases is at 57%, it's as strong as it's been in 20 years. Although Trump has indicated he wants to pull this court to the right, America and American voters are not going towards the right. So to put somebody in one of these seats that is considered a very far-right person could ultimately hurt the Republicans in the midterms."
For the full segment, [click here.](https://cheddar.com/videos/may-i-have-this-seat-predicting-next-supreme-court-justice)
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
